Businessinsider.co.za | AstraZeneca revises down its vaccine efficacy in a huge US trial - from 79% to 76%

News24

25 Mar 2021 0 shares 2 views

Businessinsider.co.za | AstraZeneca revises down its vaccine efficacy in a huge US trial - from 79% to 76%

Businessinsider.co.za | AstraZeneca revises down its vaccine efficacy in a huge US trial - from 79% to 76%

News24

Published 25 Mar 2021

AstraZeneca said Thursday in updated results that its Covid-19 vaccine was still 100% effective at preventing severe disease and hospitalisation.

You might like

Related news coverage

When Will Kids Have A Covid-19 Vaccine?

When Will Kids Have A Covid-19 Vaccine?

Newsy 31 Mar 2021

Watch VideoResearchers test vaccines in adults first, then typically move down the age brackets and that includes Moderna and..

The United Nations In The Fight Against Covid – Analysis

The United Nations In The Fight Against Covid – Analysis

Eurasia Review

31 Mar 2021

AstraZeneca COVID-19 vaccine trial data results in revised efficacy rate

Motley Fool

26 Mar 2021

AstraZeneca revises down its vaccine efficacy in a huge US trial, from 79% to 76%, following concerns from Fauci and other experts that the results were outdated
Business Insider 25 Mar 2021
AstraZeneca COVID-19 vaccine shows 76% efficacy against symptomatic infection in updated data
Upworthy 25 Mar 2021

Advertisement

More coverage

AstraZeneca says COVID-19 vaccine shows 76% efficacy in updated analysis of U.S. trial

CBC.ca 25 Mar 2021

AstraZeneca said its COVID-19 vaccine had a 76 per cent efficacy rate at preventing symptomatic illness in a new analysis of its..

News24.com | AstraZeneca lowers vaccine efficacy to 76% in updated US trial data
News24 25 Mar 2021
AstraZeneca revises down efficacy rate of US Covid-19 vaccine trial
Upworthy 25 Mar 2021
AstraZeneca says its vaccine shows 76 percent efficacy after questions arise about 'outdated information'
Upworthy 25 Mar 2021
AstraZeneca COVID-19 vaccine 76% effective in updated U.S. trial results
Hindu 25 Mar 2021